Retatrutide is a research compound designed to act on three different metabolic signaling pathways at once — including the GLP-1 and GIP pathways involved in blood sugar and appetite, plus the glucagon pathway involved in energy use. That "triple action" is what makes it one of the most closely watched compounds in current metabolic research.

In research settings, scientists have studied how it affects insulin release, the way the body burns and stores fat, appetite signaling, and overall energy expenditure.

Key Terms:

• Signaling pathway: A chain of chemical messages inside the body that tells cells how to respond — for example, when to release insulin or use fat for energy.

For Research Use Only. This product is sold strictly for laboratory and research purposes. It is not a drug, food, dietary supplement, or cosmetic, and is not intended to diagnose, treat, cure, or prevent any disease. It is not for human or veterinary use or consumption. This product has not been evaluated by the FDA. It must be handled only by qualified individuals trained in laboratory procedures. By purchasing, you affirm that you are a qualified researcher or institution and will comply with all applicable laws.